Edinburgh Molecular Imaging appoints Dr Rob James as Non-Executive Chairman

Rob is currently the Managing Partner of Sixth Element Capital and has over 20 years of experience of working in early-stage companies developing oncology drugs. He first worked at Cancer Research Campaign Technology (now Cancer Research Technology) for 7 years prior to moving in the early-stage venture capital with Prelude Ventures. He was a founding partner of DFJ Esprit before creating Sixth Element Capital in 2010. Rob has a PhD in Biochemistry and a degree in Genetics.